TCL Archive In Brief: Final appropriations for NCI Still Probably $875 Million; US-USR Drug Book Available July 1, 1977
TCL Archive In Brief: $100 Million Being Spent On Interferon In U.S., Rauscher Says; DeVita; Criticism Deserved April 4, 1980
TCL Archive Tissue of Origin Test Consistent With Diagnosis In Blinded Validation Study January 28, 2011
TCL Archive New Phase III Trial Reviews Approve 25%; Should Trialists Worry? Not Yet, January 19, 2007
TCL Archive Regorafenib Trial Meets Primary Endpoint; Overall Survival Improved by 29 Percent January 27, 2012
TCL Archive Working Group Considering formal Cap On size of Cancer Center Support Grants March 22, 1996
